Evidence map›Paper›PMID 26459757›Full record

ArticleMolecular and cellular biology2016

β-Catenin Upregulates the Constitutive and Virus-Induced Transcriptional Capacity of the Interferon Beta Promoter through T-Cell Factor Binding Sites.

Vasco Marcato, Lionel Luron, Lucie M Laqueuvre, Dominique Simon, Zeyni Mansuroglu, Marie Flamand, Jean-Jacques Panthier, Sylvie Souès, Charbel Massaad, Eliette Bonnefoy

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Vasco MarcatoINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Lionel LuronINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Lucie M LaqueuvreINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Dominique SimonInstitut Pasteur, Unité de Génétique Fonctionnelle de la Souris, Paris, France Centre National de la Recherche Scientifique URA 2578, Paris, France.
Zeyni MansurogluINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Marie FlamandInstitut Pasteur, Unité de Recherche de Virologie Structurale, Paris, France.
Jean-Jacques PanthierInstitut Pasteur, Unité de Génétique Fonctionnelle de la Souris, Paris, France Centre National de la Recherche Scientifique URA 2578, Paris, France.
Sylvie SouèsINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Charbel MassaadINSERM UMR-S1124, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Eliette BonnefoyINSERM UMR-S1007, Université Paris Descartes, Sorbonne Paris Cité, Paris, France eliette.bonnefoy@parisdescartes.fr.
Inserm · FRDélégation Paris 5 · FRInstitut Pasteur · FRUniversité Paris Cité · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid upregulation of interferon beta (IFN-β) expression following virus infection is essential to set up an efficient innate antiviral response. Biological roles related to the antiviral and immune response have also been associated with the constitutive production of IFN-β in naive cells. However, the mechanisms capable of modulating constitutive IFN-β expression in the absence of infection remain largely unknown. In this work, we demonstrate that inhibition of the kinase glycogen synthase kinase 3 (GSK-3) leads to the upregulation of the constitutive level of IFN-β expression in noninfected cells, provided that GSK-3 inhibition is correlated with the binding of β-catenin to the IFN-β promoter. Under these conditions, IFN-β expression occurred through the T-cell factor (TCF) binding sites present on the IFN-β promoter independently of interferon regulatory factor 3 (IRF3). Enhancement of the constitutive level of IFN-β per se was able to confer an efficient antiviral state to naive cells and acted in synergy with virus infection to stimulate virus-induced IFN-β expression. Further emphasizing the role of β-catenin in the innate antiviral response, we show here that highly pathogenic Rift Valley fever virus (RVFV) targets the Wnt/β-catenin pathway and the formation of active TCF/β-catenin complexes at the transcriptional and protein level in RVFV-infected cells and mice.

Indexed as

Promoter Regions, GeneticUp-RegulationAnimalsbeta CateninBinding SitesGlycogen Synthase Kinase 3Interferon-betaMiceRift Valley fever virusSignal TransductionTCF Transcription FactorsT-LymphocytesTranscriptional Activationbeta CateninCTNNB1 protein, mouseGlycogen Synthase Kinase 3Interferon-betaTCF Transcription Factors

Identifiers

PMID26459757
PMCPMC4702592
OpenAlexW2266298284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.